AARD
Aardvark Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 23, 2026 3:59:59 PM EDT

1.46USD-63.258%(-2.50)15,973,617

Pre-marketOct 23, 2026 9:29:30 AM EDT

2.94USD-25.758%(-1.02)

After-hoursOct 23, 2026 4:42:30 PM EDT

1.4698USD+1.017%(+0.0148)

1.2600Bid1.4800Ask0.2200Spread

AARD News

Day breaks

Oct 23, 2026

07:00 AM EDTAardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials ·

GlobeNewswire Inc.

Oct 22, 2026

05:27 PM EDTAardvark Therapeutics stock surges as FDA lifts clinical hold ·

Investing.com

04:05 PM EDTAardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data ·

GlobeNewswire Inc.

Oct 19, 2026

08:44 AM EDTH.C. Wainwright cuts Aardvark Therapeutics price target on trial termination ·

Investing.com

Oct 13, 2026

03:53 PM EDTAARD DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD ·

Newsfile

09:48 AM EDTCLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 ·

Business Wire

Oct 12, 2026

05:34 PM EDTAARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit ·

PR Newswire

03:48 PM EDTAARD DEADLINE TOMORROW: ROSEN, REGARDED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD ·

Newsfile

02:00 PM EDTAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit ·

PR Newswire

12:05 PM EDTDEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 ·

Newsfile

11:43 AM EDTAARD FINAL DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit ·

PR Newswire

10:31 AM EDTPrader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight ·

PR Newswire

02:29 AM EDTAardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD ·

PR Newswire

02:28 AM EDTAARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law ·

PR Newswire

Oct 11, 2026

01:15 PM EDTAARD DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD ·

Newsfile

10:50 AM EDTAARD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 ·

Newsfile

Oct 10, 2026

12:23 PM EDTAARD DEADLINE TUESDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD ·

Newsfile

Oct 9, 2026

01:10 PM EDTAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit ·

PR Newswire

12:20 PM EDTAARD FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD ·

Newsfile

Oct 8, 2026

02:52 PM EDTAARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law ·

PR Newswire

AARDAardvark Therapeutics, Inc. Common StockstockNASDAQ

AARD
Aardvark Therapeutics, Inc. Common Stock
stockNASDAQ